Paris, France

Agnes Pottier

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 28(Granted Patents)


Location History:

  • Bourg la Reine, FR (2014)
  • Paris, FR (2017 - 2023)

Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Agnes Pottier: Innovator in Nanomedicine

Introduction

Agnes Pottier is a prominent inventor based in Paris, France, known for her groundbreaking work in the field of nanomedicine. With a total of 13 patents to her name, she has made significant contributions to the development of innovative treatments for cancer and other medical applications.

Latest Patents

Among her latest patents is a remarkable invention involving inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer. This application focuses on activable inorganic nanoparticles that can effectively disturb, alter, or destroy target cancerous cells, tissues, or organs. The nanoparticles generate a surprisingly efficient therapeutic effect when concentrated inside tumors and exposed to ionizing radiations. Another notable patent relates to pharmaceutical compositions that combine biocompatible nanoparticles with compounds of interest, enhancing the bioavailability of pharmaceutical compounds administered to patients.

Career Highlights

Agnes Pottier has worked with notable companies in the field, including Nanobiotix and Curadigm Sas. Her work has been instrumental in advancing the application of nanotechnology in medicine, particularly in cancer treatment.

Collaborations

Agnes has collaborated with esteemed colleagues such as Laurent Levy and Matthieu Germain, contributing to the advancement of innovative medical solutions.

Conclusion

Agnes Pottier's contributions to nanomedicine and her innovative patents highlight her role as a leading inventor in the health sector. Her work continues to pave the way for new therapeutic approaches in treating cancer and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…